Cytosorbents Corp financial data

Symbol
CTSO on Nasdaq
Location
Princeton, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 231% % 23%
Quick Ratio 34% % 3.7%
Debt-to-equity 315% % 82%
Return On Equity -89% % 17%
Return On Assets -21% % 45%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62,804,305 shares 15%
Common Stock, Shares, Outstanding 62,794,305 shares 15%
Entity Public Float $37,100,000 USD -74%
Common Stock, Value, Issued $63,000 USD 16%
Weighted Average Number of Shares Outstanding, Basic 62,753,959 shares 15%
Weighted Average Number of Shares Outstanding, Diluted 62,753,959 shares 15%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $9,715,538 USD -35%
Operating Income (Loss) $14,093,779 USD 37%
Nonoperating Income (Expense) $1,732,350 USD -35%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,571,000 USD -29%
Income Tax Expense (Benefit) $401,000 USD
Net Income (Loss) Attributable to Parent $10,269,604 USD 48%
Earnings Per Share, Basic 0 USD/shares 50%
Earnings Per Share, Diluted 0 USD/shares 50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,536,000 USD 33%
Accounts Receivable, after Allowance for Credit Loss, Current $7,427,000 USD 12%
Inventory, Net $4,002,000 USD 23%
Assets, Current $21,313,000 USD 28%
Property, Plant and Equipment, Net $8,193,000 USD -12%
Operating Lease, Right-of-Use Asset $11,075,000 USD -4.9%
Other Assets, Noncurrent $3,647,000 USD -4.1%
Assets $45,750,000 USD -4.3%
Accounts Payable, Current $3,035,000 USD 30%
Contract with Customer, Liability, Current $403,000 USD
Liabilities, Current $10,112,000 USD 22%
Operating Lease, Liability, Noncurrent $12,051,000 USD -4.1%
Liabilities $36,730,000 USD 6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $3,844,000 USD -2350%
Retained Earnings (Accumulated Deficit) $306,710,000 USD -3.5%
Stockholders' Equity Attributable to Parent $9,020,000 USD -33%
Liabilities and Equity $45,750,000 USD -4.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,464,955 USD 28%
Net Cash Provided by (Used in) Financing Activities $6,832,134 USD
Net Cash Provided by (Used in) Investing Activities $47,242 USD 63%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 62,794,305 shares 15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,345,849 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9,058,000 USD -26%
Interest Paid, Excluding Capitalized Interest, Operating Activities $506,250 USD 154%
Deferred Tax Assets, Valuation Allowance $48,267,681 USD 6.5%
Deferred Tax Assets, Gross $51,853,067 USD 5.7%
Operating Lease, Liability $12,569,000 USD -3.3%
Depreciation $300,000 USD 0%
Payments to Acquire Property, Plant, and Equipment $2,121 USD -95%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $13,653,129 USD 40%
Lessee, Operating Lease, Liability, to be Paid $21,176,000 USD -7.4%
Property, Plant and Equipment, Gross $13,482,000 USD
Operating Lease, Liability, Current $518,000 USD 20%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,777,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,736,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8,607,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,819,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $39,315,800 USD 6.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $2,200,000 USD 4.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,863,000 USD 3%
Operating Lease, Payments $1,816,376 USD -17%
Additional Paid in Capital $319,511,000 USD 3.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $3,585,386 USD -3.2%
Share-based Payment Arrangement, Expense $3,658,961 USD -15%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%